Retinoic acids and hepatic stellate cells in liver disease

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue SUPPL.2, 2012, Pages 75-79

  Lee, Young Sun ^a   Jeong, Won Il ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

Immune regulation; Natural killer cells; Retinoic acid early inducible 1; Suppressor of cytokine signaling 1

Indexed keywords

RETINOIC ACID; RETINOL;

CELL METABOLISM; CYTOTOXICITY; FATTY LIVER; HEPATITIS; HUMAN; IMMUNOCOMPETENT CELL; LIVER CELL; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FIBROSIS; LIVER REGENERATION; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; STELLATE CELL; T LYMPHOCYTE;

EID: 84863082047     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.07007.x     Document Type: Review

References (49)

1. Blomhoff R, Blomhoff HK. Overview of retinoid metabolism and function. J. Neurobiol. 2006; 66: 606-30.
2. Theodosiou M, Laudet V, Schubert M. From carrot to clinic: an overview of the retinoic acid signaling pathway. Cell. Mol. Life Sci. 2010; 67: 1423-45.
3. Kawaguchi R, Yu J, Honda J etal. A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A. Science 2007; 315: 820-5.
4. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev. 2008; 88: 125-72.
5. Jeong WI, Osei-Hyiaman D, Park O etal. Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver. Cell Metab. 2008; 7: 227-35.
6. Sauvant P, Sapin V, Alexandre-Gouabau MC etal. Retinol mobilization from cultured rat hepatic stellate cells does not require retinol binding protein synthesis and secretion. Int. J. Biochem. Cell Biol. 2001; 33: 1000-12.
7. Duester G, Mic FA, Molotkov A. Cytosolic retinoid dehydrogenases govern ubiquitous metabolism of retinol to retinaldehyde followed by tissue-specific metabolism to retinoic acid. Chem. Biol. Interact. 2003; 143-144: 201-10.
8. Molotkov A, Fan X, Deltour L etal. Stimulation of retinoic acid production and growth by ubiquitously expressed alcohol dehydrogenase Adh3. Proc. Natl Acad. Sci. U.S.A. 2002; 99: 5337-42.
9. Radaeva S, Wang L, Radaev S, Jeong WI, Park O, Gao B. Retinoic acid signaling sensitizes hepatic stellate cells to NK cell killing via upregulation of NK cell activating ligand RAE1. Am. J. Physiol. Gastrointest. Liver Physiol. 2007; 293: G809-816.
10. Casini A, Pellegrini G, Ceni E etal. Human hepatic stellate cells express class I alcohol dehydrogenase and aldehyde dehydrogenase but not cytochrome P4502E1. J. Hepatol. 1998; 28: 40-5.
11. Yang L, Jung Y, Omenetti A etal. Fate-mapping evidence that hepatic stellate cells are epithelial progenitors in adult mouse livers. Stem Cells 2008; 26: 2104-13.
12. Higashi N, Sato M, Kojima N etal. Vitamin A storage in hepatic stellate cells in the regenerating rat liver: with special reference to zonal heterogeneity. Anat. Rec. A. Discov Mol Cell Evol. Biol. 2005; 286: 899-907.
13. Lopez-Valencia V, Rangel P, Rodriguez S, Hernandez-Munoz R. Involvement of alcohol and aldehyde dehydrogenase activities on hepatic retinoid metabolism and its possible participation in the progression of rat liver regeneration. Biochem. Pharmacol. 2007; 73: 586-96.
14. Wang SC, Ohata M, Schrum L, Rippe RA, Tsukamoto H. Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells. J. Biol. Chem. 1998; 273: 302-8.
15. Winau F, Hegasy G, Weiskirchen R etal. Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 2007; 26: 117-29.
16. Radaeva S, Sun R, Jaruga B, Nguyen VT, Tian Z, Gao B. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology 2006; 130: 435-52.
17. Ichikawa S, Mucida D, Tyznik AJ, Kronenberg M, Cheroutre H. Hepatic stellate cells function as regulatory bystanders. J. Immunol. 2011; 186: 5549-55.
18. Lan RY, Salunga TL, Tsuneyama K etal. Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J. Autoimmun. 2009; 32: 43-51.
19. Lafdil F, Miller AM, Ki SH, Gao B. Th17 cells and their associated cytokines in liver diseases. Cell. Mol. Immunol. 2010; 7: 250-4.
20. Mucida D, Park Y, Kim G etal. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007; 317: 256-60.
21. Sun CM, Hall JA, Blank RB etal. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 2007; 204: 1775-85.
22. Bonet ML, Ribot J, Palou A. Lipid metabolism in mammalian tissues and its control by retinoic acid. Biochim. Biophys. Acta 2012; 1821: 177-89.
23. Yanagitani A, Yamada S, Yasui S etal. Retinoic acid receptor alpha dominant negative form causes steatohepatitis and liver tumors in transgenic mice. Hepatology 2004; 40: 366-75.
24. Mukhopadhyay B, Liu J, Osei-Hyiaman D etal. Transcriptional regulation of cannabinoid receptor-1 expression in the liver by retinoic acid acting via retinoic acid receptor-gamma. J. Biol. Chem. 2010; 285: 19002-11.
25. Natarajan SK, Thomas S, Ramachandran A, Pulimood AB, Balasubramanian KA. Retinoid metabolism during development of liver cirrhosis. Arch. Biochem. Biophys. 2005; 443: 93-100.
26. Parkes JG, Templeton DM. Effects of retinol and hepatocyte-conditioned medium on cultured rat hepatic stellate cells. Ann. Clin. Lab. Sci. 2003; 33: 295-305.
27. Senoo H, Wake K. Suppression of experimental hepatic fibrosis by administration of vitamin A. Lab. Invest. 1985; 52: 182-94.
28. Murakami K, Kaji T, Shimono R etal. Therapeutic effects of vitamin A on experimental cholestatic rats with hepatic fibrosis. Pediatr. Surg. Int. 2011; 27: 863-70.
29. Sato Y, Murase K, Kato J etal. Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone. Nat. Biotechnol. 2008; 26: 431-42.
30. Kluwe J, Wongsiriroj N, Troeger JS etal. Absence of hepatic stellate cell retinoid lipid droplets does not enhance hepatic fibrosis but decreases hepatic carcinogenesis. Gut 2011; 60: 1260-8.
31. Hisamori S, Tabata C, Kadokawa Y etal. All-trans-retinoic acid ameliorates carbon tetrachloride-induced liver fibrosis in mice through modulating cytokine production. Liver Int. 2008; 28: 1217-25.
32. Wang L, Tankersley LR, Tang M, Potter JJ, Mezey E. Regulation of the murine alpha(2)(I) collagen promoter by retinoic acid and retinoid X receptors. Arch. Biochem. Biophys. 2002; 401: 262-70.
33. Davis BH, Rapp UR, Davidson NO. Retinoic acid and transforming growth factor beta differentially inhibit platelet-derived-growth-factor-induced Ito-cell activation. Biochem. J. 1991; 278 (Pt 1): 43-7.
34. Jameel NM, Thirunavukkarasu C, Wu T, Watkins SC, Friedman SL, Gandhi CR. p38-MAPK- and caspase-3-mediated superoxide-induced apoptosis of rat hepatic stellate cells: reversal by retinoic acid. J. Cell. Physiol. 2009; 218: 157-66.
35. Ohata M, Lin M, Satre M, Tsukamoto H. Diminished retinoic acid signaling in hepatic stellate cells in cholestatic liver fibrosis. Am. J. Physiol. 1997; 272: G589-596.
36. Mezaki Y, Yoshikawa K, Yamaguchi N etal. Rat hepatic stellate cells acquire retinoid responsiveness after activation in vitro by post-transcriptional regulation of retinoic acid receptor alpha gene expression. Arch. Biochem. Biophys. 2007; 465: 370-9.
37. Okuno M, Moriwaki H, Imai S etal. Retinoids exacerbate rat liver fibrosis by inducing the activation of latent TGF-beta in liver stellate cells. Hepatology 1997; 26: 913-21.
38. Jeong WI, Park O, Suh YG etal. Suppression of innate immunity (natural killer cell/interferon-gamma) in the advanced stages of liver fibrosis in mice. Hepatology 2011; 53: 1342-51.
39. Hellemans K, Grinko I, Rombouts K, Schuppan D, Geerts A. All-trans and 9-cis retinoic acid alter rat hepatic stellate cell phenotype differentially. Gut 1999; 45: 134-42.
40. Hellemans K, Verbuyst P, Quartier E etal. Differential modulation of rat hepatic stellate phenotype by natural and synthetic retinoids. Hepatology 2004; 39: 97-108.
41. Milliano MT, Luxon BA. Rat hepatic stellate cells become retinoid unresponsive during activation. Hepatol. Res. 2005; 33: 225-33.
42. Jeong WI, Park O, Radaeva S, Gao B. STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity. Hepatology 2006; 44: 1441-51.
43. Zhao Z, Murasko DM, Ross AC. The role of vitamin A in natural killer cell cytotoxicity, number and activation in the rat. Nat. Immun. 1994; 13: 29-41.
44. Zhao Z, Ross AC. Retinoic acid repletion restores the number of leukocytes and their subsets and stimulates natural cytotoxicity in vitamin A-deficient rats. J. Nutr. 1995; 125: 2064-73.
45. Okuno M, Sato T, Kitamoto T etal. Increased 9, 13-di-cis-retinoic acid in rat hepatic fibrosis: implication for a potential link between retinoid loss and TGF-beta mediated fibrogenesis in vivo. J. Hepatol. 1999; 30: 1073-80.
46. Clemente C, Elba S, Buongiorno G, Berloco P, Guerra V, Di Leo A. Serum retinol and risk of hepatocellular carcinoma in patients with Child-Pugh class A cirrhosis. Cancer Lett. 2002; 178: 123-9.
47. Santhanam U, Lalitha VS, Bhide SV. Carcinogenicity of diethylnitrosamine in vitamin-A-deficient mice. Int. J. Cancer 1987; 40: 784-7.
48. Shao RX, Otsuka M, Kato N etal. Acyclic retinoid inhibits human hepatoma cell growth by suppressing fibroblast growth factor-mediated signaling pathways. Gastroenterology 2005; 128: 86-95.
49. Kuang DM, Peng C, Zhao Q, Wu Y, Chen MS, Zheng L. Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells. Hepatology 2010; 51: 154-64.